Exagen Q1 Net Loss Widens, Reaffirms Full-Year Revenue Guidance
05:02 PM EDT, 05/11/2021 (MT Newswires) -- Exagen (XGN) reported Tuesday a Q1 net loss of $0.48 per share, compared with a loss of $0.44 per share a year earlier.
Analysts polled by Capital IQ expected a net loss per share of $0.45.
Revenue totaled $10.6 million, up from $9.6 million a year earlier. The Street forecast was for $10.5 million.
The company reaffirmed its full-year revenue guidance of between $47 million and $49 million, versus the consensus estimate of $48 million.
Price: 15.06, Change: -0.11, Percent Change: -0.73